These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36441658)

  • 41. Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?
    Omma A; Tecer D; Kucuksahin O; Sandikci SC; Yildiz F; Erten S
    Arch Med Sci; 2018 Jun; 14(4):830-837. PubMed ID: 30002701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease phenotype and diagnostic delay in Saudi patients with primary Sjögren's syndrome: An exploratory cross-sectional study.
    Omair MA; AlQahtani BS; AlHamad EH; Tashkandy YA; Othman NS; AlShahrani KA; Paramasivam MP; AlEnzi F; Halwani R; Daghestani MH
    Saudi Med J; 2021 Apr; 42(4):405-410. PubMed ID: 33795496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort.
    Billings M; Amin Hadavand M; Alevizos I
    Oral Dis; 2018 Mar; 24(1-2):184-190. PubMed ID: 29480635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome.
    Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; De Craemer AS; Van den Bosch F; Elewaut D; Peene I
    Semin Arthritis Rheum; 2022 Oct; 56():152075. PubMed ID: 35907342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation and adaptation to Spanish of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).
    Posso-Osorio I; Nieto-Aristizábal I; Soto D; Ariza C; Urbano M; Cañas CA; Echeverri A; Castillo A; Tobón GJ
    Reumatol Clin (Engl Ed); 2021; 17(7):388-391. PubMed ID: 34301381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cross-sectional study on activity impairment in primary Sjogren's syndrome.
    Yenissoy Y; Altıngöz EN; Kapusuz A; Abacar K; Tatlı I; Türe-Özdemir F; Karacaylı U; Yay M; Direskeneli H; Fortune F; Inanc N; Mumcu G
    Oral Dis; 2024 May; 30(4):2234-2244. PubMed ID: 37246927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
    Wang X; Bootsma H; Terpstra J; Vissink A; van der Vegt B; Spijkervet FKL; Kroese FGM; Pringle S
    Rheumatology (Oxford); 2020 Oct; 59(10):3003-3013. PubMed ID: 32159757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients.
    Tsuboi H; Hagiwara S; Asashima H; Takahashi H; Hirota T; Noma H; Umehara H; Kawakami A; Nakamura H; Sano H; Tsubota K; Ogawa Y; Takamura E; Saito I; Inoue H; Nakamura S; Moriyama M; Takeuchi T; Tanaka Y; Hirata S; Mimori T; Matsumoto I; Sumida T
    Ann Rheum Dis; 2017 Dec; 76(12):1980-1985. PubMed ID: 28330998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation and psychometric properties of the Eular Sjögren's Syndrome Patient Reported Index (ESSPRI) into Brazilian Portuguese.
    Paganotti MA; Valim V; Serrano ÉV; Miyamoto ST; Giovelli RA; Santos MC
    Rev Bras Reumatol; 2015; 55(5):439-45. PubMed ID: 26345467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral neuropathy and health-related quality of life in patients with primary Sjögren's syndrome: a preliminary report.
    Jaskólska M; Chylińska M; Masiak A; Nowicka-Sauer K; Siemiński M; Ziętkiewicz M; Czuszyńska Z; Zdrojewski Z
    Rheumatol Int; 2020 Aug; 40(8):1267-1274. PubMed ID: 32172462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
    Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
    Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of primary Sjögren's syndrome on female sexual function.
    van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
    Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kynurenine pathway can be a potential biomarker of fatigue in primary Sjögren's syndrome.
    Park Y; Lee JJ; Koh JH; Kim MJ; Park SH; Kwok SK
    Clin Exp Rheumatol; 2023 Dec; 41(12):2363-2370. PubMed ID: 36826785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease.
    Georgel L; Benyoussef AA; Berrouiguet S; Guellec D; Carvajal Alegria G; Marhadour T; Jousse-Joulin S; Cochener-Lamard B; Labetoulle M; Gottenberg JE; Bourcier T; Nocturne G; Saraux A; Mariette X; Consigny M; Gravey M; Devauchelle-Pensec V; Seror R; Cornec D
    RMD Open; 2024 Oct; 10(4):. PubMed ID: 39357926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome.
    Le Goff M; Cornec D; Jousse-Joulin S; Guellec D; Costa S; Marhadour T; Le Berre R; Genestet S; Cochener B; Boisrame-Gastrin S; Renaudineau Y; Pers JO; Saraux A; Devauchelle-Pensec V
    Arthritis Res Ther; 2017 Dec; 19(1):269. PubMed ID: 29208023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anxiety and depression in primary Sjögren's syndrome: a cross-sectional study.
    Cui Y; Xia L; Li L; Zhao Q; Chen S; Gu Z
    BMC Psychiatry; 2018 May; 18(1):131. PubMed ID: 29769121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjögren Syndrome.
    DiRenzo DD; Robinson S; Bingham CO; Baer AN; Grader-Beck T
    J Rheumatol; 2022 May; 49(5):470-474. PubMed ID: 35169058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.